Cargando…
The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence
BACKGROUND: Genetic mitochondrial diseases represent a significant challenge to human health. These diseases are extraordinarily heterogeneous in clinical presentation and genetic origin, and often involve multi-system disease with severe progressive symptoms. Mitochondrial diseases represent the mo...
Autores principales: | Hanaford, Allison, Johnson, Simon C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438277/ https://www.ncbi.nlm.nih.gov/pubmed/36056365 http://dx.doi.org/10.1186/s13023-022-02495-3 |
Ejemplares similares
-
AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives
por: Hanaford, Allison R., et al.
Publicado: (2022) -
HMBG1 as a Driver of Inflammatory and Immune Processes in the Pathogenesis of Ocular Diseases
por: Liu, Yi, et al.
Publicado: (2018) -
Volatile anaesthetic toxicity in the genetic mitochondrial disease Leigh syndrome
por: Spencer, Kira A., et al.
Publicado: (2023) -
Alterations in mitochondrial morphology as a key driver of immunity and host defence
por: Cervantes‐Silva, Mariana P, et al.
Publicado: (2021) -
Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A Review
por: Alshemmari, Salem H., et al.
Publicado: (2016)